Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV001289292 | SCV001477020 | benign | not specified | 2020-07-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001518294 | SCV001726962 | benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2024-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002354863 | SCV002650286 | likely benign | Inborn genetic diseases | 2018-03-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003413763 | SCV004137990 | benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | CACNA1A: BS1, BS2 |